![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
01 (4S,6S)-5, 6-DIHYDRO-4-HYDROXY-6-METHYL-4H-THIENO[2,3-B]THIOPYRAN 7,7-DIOXIDE ("HSOT") (1)
02 HPG DANE SALT (1)
03 KPM-1648 (1)
04 MANUFACTURING SITE, FACILITIES, PERSONNEL AND GENERAL OPERATING PROCEDURES AT TAKASAGO-SHI HYOGO, JAPAN (1)
05 N-2-[1-(S)-ETHOXYCARBONYL]-N-6-TRIFLUOROACETYL-1-LYSYL-N-2-CARBOXY ANHYDRIDE(EPTL) (1)
06 N-[1(S)-ETHOXYCARBONYL-3-PHENYLPROPYL]-L-ALANINE (ALE) (1)
07 N-[1(S)-ETHOXYCARBONYL-3-PHENYLPROPYL]-L-ALANYL-N-CARBOXY ANHYDRIDE (1)
08 N2-[1-(S)-ETHOXYCARBONYL 1-3-PHENYLPROPYL]-N6-TRIFLUOROACETYL-L-LYSYL-L-PROLINE. (1)
09 PCE (1)
10 PRODUCTION OF PLASMID DNA (1)
11 PRODUCTION OF PLASMID DNA (DRUG SUBSTANCE, VERSION 2) (1)
12 PRODUCTION OF PLASMID DNA VERSION 3 (1)
13 PRODUCTION OF PLASMID DNA VERSION 4 (1)
14 PRODUCTION OF PLASMID DNA, VERSION 5 (1)
15 UBIDECARENONE (2)
01 KANEKA AMERICA CORP (1)
02 KANEKA AMERICA LLC (1)
03 KANEKA CORP (3)
04 KANEKA CORPORATION JAPAN (5)
05 KANEKA EUROGENTEC SA (5)
06 KANEKA SINGAPORE CO PTE LTD (1)
01 Belgium (11)
02 Japan (1)
03 U.S.A (4)
01 Active (11)
02 Inactive (5)
01 Blank (16)